Advertisement

Toll of Mental Disorders: TLR-Mediated Function of the Innate Immune System

  • Jian-Feng LiuEmail author
  • Ruyan Wu
  • Jun-Xu LiEmail author
RESEARCH HIGHLIGHT
  • 16 Downloads

Mental disorder is defined as a syndrome characterized by clinically significant disturbance in an individual’s cognition, emotion, or behavior that reflects a dysfunction in the psychological, biological, or developmental processes underlying mental functioning (DSM-V). The economic cost of mental disorders is increasing along with the increased prevalence of mental disorders worldwide. According to the 2016 National Survey on Drug Use and Health, nearly 18.5% of adults are experiencing mental disorders in the United States (http://www.nimh.nih.gov/health/statistics/prevalence/any-mental-illness-ami-among-adults.shtml). However, our poor understanding of the complicated pathology of mental disorders is an obstacle to the development of effective treatments.

Traditional opinions on the pathology of most mental disorders focus on disturbances of specific neurotransmitters [1]. For example, major depression, the most common mental disorder, is linked with abnormal regulation of...

Notes

Acknowledgements

This work was supported by the National Institutes of Health National Institute on Drug Abuse (R21DA040777). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1.
    Sachar EJ, Baron M. The biology of affective disorders. Annu Rev Neurosci 1979, 2: 505–517.CrossRefGoogle Scholar
  2. 2.
    Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006, 7: 137–151.CrossRefGoogle Scholar
  3. 3.
    Hutchinson MR. ‘Convergence’ created psychoneuroimmunology, and is needed again to secure the future of the field. Brain Behav Immun 2018, 71: 1–2.CrossRefGoogle Scholar
  4. 4.
    Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9: 46–56.CrossRefGoogle Scholar
  5. 5.
    Nie X, Kitaoka S, Tanaka K, Segi-Nishida E, Imoto Y, Ogawa A, et al. The innate immune receptors TLR2/4 mediate repeated social defeat stress-induced social avoidance through prefrontal microglial activation. Neuron 2018, 99: 464–479 e7.Google Scholar
  6. 6.
    Bachtell R, Hutchinson MR, Wang X, Rice KC, Maier SF, Watkins LR. Targeting the Toll of drug abuse: the translational potential of Toll-like receptor 4. CNS Neurol Disord Drug Targets 2015, 14: 692–699.CrossRefGoogle Scholar
  7. 7.
    Kashima DT, Grueter BA. Toll-like receptor 4 deficiency alters nucleus accumbens synaptic physiology and drug reward behavior. Proc Natl Acad Sci U S A 2017, 114: 8865–8870.CrossRefGoogle Scholar
  8. 8.
    Theberge FR, Li X, Kambhampati S, Pickens CL, St Laurent R, Bossert JM, et al. Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving. Biol Psychiatry 2013, 73: 729–737.CrossRefGoogle Scholar
  9. 9.
    Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, Zhao TX, et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun 2010, 24: 83–95.CrossRefGoogle Scholar
  10. 10.
    Sorge RE, Mapplebeck JC, Rosen S, Beggs S, Taves S, Alexander JK, et al. Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nat Neurosci 2015, 18: 1081–1083.CrossRefGoogle Scholar
  11. 11.
    Liu T, Gao YJ, Ji RR. Emerging role of Toll-like receptors in the control of pain and itch. Neurosci Bull 2012, 28: 131–144.CrossRefGoogle Scholar
  12. 12.
    Doyle HH, Murphy AZ. Sex differences in innate immunity and its impact on opioid pharmacology. J Neurosci Res 2017, 95: 487–499.CrossRefGoogle Scholar
  13. 13.
    Alfonso-Loeches S, Pascual M, Guerri C. Gender differences in alcohol-induced neurotoxicity and brain damage. Toxicology 2013, 311: 27–34.CrossRefGoogle Scholar
  14. 14.
    Femenia T, Qian Y, Arentsen T, Forssberg H, Diaz Heijtz R. Toll-like receptor-4 regulates anxiety-like behavior and DARPP-32 phosphorylation. Brain Behav Immun 2018, 69: 273–282.CrossRefGoogle Scholar

Copyright information

© Shanghai Institutes for Biological Sciences, CAS 2019

Authors and Affiliations

  1. 1.Department of Pharmacology and ToxicologyUniversity at BuffaloBuffaloUSA
  2. 2.School of MedicineYangzhou UniversityYangzhouChina

Personalised recommendations